Asthma
Remotely monitor wheeze and cough in asthma patients with the RESP® Biosensor
As clinicians and drug developers look for asthma monitoring devices to strengthen disease surveillance and insight into treatment response, continuous cough and wheeze monitoring offers a promising approach. Wheezing, a hallmark symptom of asthma and an indication of airway obstruction is typically observed only subjectively by patients or clinicians via auscultation. Cough is also a prevalent, burdensome symptom in asthma — especially in cough variant asthma — and a common early sign of an attack.3
Meet the RESP® Biosensor: The Most Advanced Asthma Monitoring Device
- Clinically validated accuracy, with equivalent performance to Littman 3200 stethoscope.
- Continuous monitoring of cough and lung sounds such as wheeze to offer quantitative data on respiratory symptoms in daily life.
- Patient-friendly, reduces the burden on patients while improving clinician efficiency.
How It Works
An end-to-end solution for remote monitoring of lung health
RESP® Biosensor
Patient adheres wearable device to their chest; device continuously captures lung sounds including wheeze throughout the day/night
Strados™ Mobile App
Lung sound data collected by the device is transferred to a companion patient mobile app via Bluetooth
Strados™ Cloud
Cloud securely stores data where lung sound events such as cough and wheeze are tracked and trended
Initial results from the study which took place at Ann & Lurie Children’s Hospital in Chicago showed positive feedback from patients and families as well as strong accuracy in detecting wheeze compared to physician auscultation.
TESTIMONIAL VIDEO
Hear from Sadia Benzaquen, MD, Director of Pulmonary & Critical Care at Einstein Philadelphia Hospital
Download the Strados Publication
Continuous Wheeze Monitoring Versus Intermittent Auscultation of Wheezes
For Healthcare
Improve management of adult and pediatric asthma with real-time monitoring of cough and wheeze
For Life Sciences
Gain greater, objective insight into subject treatment response in clinical trials for asthma
Asthma Patient Reporting
- Smart Reporting in Action: Our respiratory experts, trained annotators, and machine learning algorithms work in tandem to analyze cloud-uploaded patient cough and lung sound results with exceptional clinical accuracy.
- Efficiency and Accuracy: Streamlined data annotation with our proprietary algorithms accelerates insights and optimizes research budgets, maintaining the integrity of every dataset.
Cough
Wheeze
Crackles
Clinical Validation of our Asthma Monitoring Device
Is the RESP® Biosensor reimbursable?
The RESP® Biosensor is reimbursable under RPM and RTM codes.
Is the RESP® Biosensor designed for continuous long-term monitoring?
Yes. The RESP® Biosensor was designed for long-term, continuous remote monitoring with the goal of detecting changes in lung sounds passively ranging from 4 – 24 hours per day.
Which care settings is the RESP® Biosensor intended for?
The RESP® Biosensor is designed to be used across multiple care settings, including clinical trials, in-patient, transitional care, post-acute discharge, outpatient, and hospital at home.
Let’s Talk.
References
- Wang, Z., Li, Y., Gao, Y., Fu, Y., Lin, J., Lei, X., Zheng, J., & Jiang, M. (2023). Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Respiratory research, 24(1), 169. https://doi.org/10.1186/s12931-023-02475-6
- Asthma and Allergy Foundation of America. Asthma Facts and Figures [Internet] Available at https://aafa.org/asthma/asthma-facts/
- NHS. Asthma Attacks [Internet]. https://www.nhs.uk/conditions/asthma/asthma-attack/